Marc Beer

Marc Beer’s Road to Success

In 1987, Marc Beer left his college years behind and joined the pharmaceutical industry as a sales and marketing professional. His career quickly skyrocketed when he joined Genzyme and was named Vice President of Global Marketing shortly after he started working. It was while working at Genzyme that Beer also discovered he had a passion for solving pressing and immediate problems.

After promoting a Genzyme product line to more than 350 million people around the world, Beer felt the desire to up his game. He felt restricted by Genzyme’s policies and wanted to push his talents further. A few years later, he had all the skills needed to launch his first company.

In 2000, Beer finally got around to launching that first business after finding a worthy cause. Marc Beer founded ViaCell in 2000, a company dedicated to developing treatments for several physical conditions by using umbilical cord blood stem cells. By 2005, he’d taken his company public and found out how much the rest of the world valued his efforts.

Two years later, Beer experienced the highest and lowest points in his life. First, Beer sold ViaCell to a company called PerkinElmer, which purchased ViaCell for $300 million. That same year, Beer lost his wife suddenly to a pulmonary embolism.

Marc Beer went from being on top of the world to the lowest point in a matter of months. Despite his promising career as a pharmaceutical and biotechnology entrepreneur, Beer set his career aside and focused on his family life. He found consolation in raising his three children and being a stay-at-home dad.

Today, Beer is best known as a co-founder, CEO, and Chairman of Renovia. He decided to rediscover his passion for business after his daughter began encouraging him to go back to work. After taking her advice, he found two partners to go into business with.

The first partner, Dr. Ray Iglesias, was the original mastermind behind the company. Dr. Iglesias spent 35 years performing pelvic floor surgeries and wished that there was a way for women to avoid surgery. He spent ten years developing some concepts, and when everything was developed enough, he shared those concepts with Marc Beer. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html

Later, Yolanda Lorie would join the team and Renovia would be founded. Currently, Renovia is on the cutting-edge of pelvic floor disorders treatments and therapies. Nearly 25 percent of women in the U.S. suffer from pelvic floor disorders and that’s too much suffering for Beer to sleep at night. Inspired by his wife’s death and his daughters, Beer felt obligated to join the fight.

Follow Marc Beer on Facebook

The Life and Career of Marc Beer

He has seen many ups and downs throughout a career that has spanned over three decades but that has never stopped Marc Beer from attempting to successfully help as many people as he possibly can. The 48-year-old philanthropist and entrepreneur recently sat down with Stephen Callahan to discuss how he accomplished so much over the years and what his aspirations are for the future. It all began in fall 1983 when he was a freshman at Miami University. It didn’t take him long to realize he wanted to be a business major and, within four years, he had managed to obtain his bachelor of science degree. After his academic career had concluded, he accepted a job offer to work for a company called Abbott as a member of their sales development team. 

While he enjoyed his time there, he decided to leave after six years so he could accept a job offer from Biostar Inc. While working as a corporate officer there, he was offered the position of vice president of global marketing at a corporation known as Genzyme. Upon careful deliberation, he opted to take the position and worked there for four years before leaving to open his own business. Based out of Cambridge, Viacell was founded back in May of 2000 and quickly took off with a value of over $100 million and over 300 employees working for them. After going public with the company, he unexpectedly decided to sell two years later for a whopping price of over a quarter of a million. Learn more: https://medium.com/@marc.beer

Once the sale was complete, he had to deal with a family tragedy before his career could continue. It seems his wife, Jennifer, had passed away of a pulmonary embolism and he had to step up and become the primary caregiver to his three children. For over two years, he found himself transporting them to school, attending PTA meetings and helping them with whatever they needed but, pretty soon, his daughter helped him to see that the business world still needed him. So he rounded up some business associates he knew he could trust and became the cofounder, chairman and CEO of a new business called Renovia. Based out of Boston and first established in 2016, the primary mission of the company is to develop and mass produce various kinds of medical tools designed to help those who are under the weather. 

They take pride in having one of their products receive a stamp of approval from the FDA and the company has already earned a stellar reputation and they have already raised over $42.3 million to continue developing and perfecting these products to help people around the world. So we wish him luck.

Follow Marc Beer on Facebook

Marc Beer Is A CEO In The Biotechnology Sector Who Truly Cares About The People He Serves

Marc Beer has been serving in the biotechnology sector for over 25 years, and he has helped to grow many different companies during that time. He studied at Miami University and received his Bachelor of Science degree in business in 1987. He went to work in the pharmaceutical sales sector after finishing college and eventually worked with Genzyme as its vice president of global marketing. Beer was able to make a huge difference by addressing the needs of an underserved group of people through his marketing efforts and was forever changed by doing so.

During the earlier part of the 2000s, Marc Beer decided to start up his first company, which was named VIA CELL. This biotechnology company had 300 employees, and it went public during the mid-2000s. It focused on collecting and preserving umbilical cord blood stem cells, which could be used to treat various ailments that people suffered from. He eventually sold the company for $300 million to PerkinElmer right before his wife passed away from a pulmonary embolism. Learn more: https://www.bloomberg.com/research/stocks/people/person.asp?personId=1285777&privcapId=47636573

Marc Beer focused on raising his children after his wife passed away, and it was one of his kids who inspired him to get back to work a couple of years later. He had always taught his children to live their lives with purpose, and his daughter reminded him of his own words. He got back to work, and some years later, he helped to found Renovia. He continues to serve as the company’s chairman and CEO today. The company was started up when Beer partnered up with Yolanda Lorie and Dr. Iglesias in order to create therapeutic diagnostic devices for women who suffer from pelvic floor diseases.

In 2018, all of the hard work of Marc Beer paid off when Renovia came out with its first product, which is named Leva. The Food and Drug Administration approved Leva, and he was able to go on to get venture capital funding and a Series B round of funding. Beer commented on the Series B funding by saying that his company was thrilled to be supported by a group of the top healthcare investors. He went on to talk more about the details of his company and how it will help to lower the cost of healthcare for women in the future.

Marc Beer serves Renovia as its chief executive officer and chairman, and he has been successfully running the company for years. In the past, he has also served with Good Start Genetics, Inc. as its founding chairman of the board as well as its chairman of the compensation committee. He also served with the Miami University Business Advisory Council as a member and continues to do what he feels is right by helping to improve the biotechnology industry.

Follow Marc Beer on Facebook